Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice

Psychopharmacology (Berl). 1985;86(1-2):61-7. doi: 10.1007/BF00431685.

Abstract

The amnesias characteristic of Alzheimer's disease and other age-related dementias are refractory to conventional pharmacotherapy. A recent treatment strategy is to combine present drugs to improve their memory enhancing effect. We used mice weakly trained on active avoidance in a T-maze to compare the effect of cholinergic drugs, given alone and in two-drug combinations, on retention test performance. All drugs were injected SC immediately after training. Memory retention was tested 1 week later. A dose-response curve was determined for each of four drugs (arecoline, edrophonium, oxotremorine, tacrine) and for each of the six possible two-drug combinations. Each drug and each combination improved retention test performance up to an optimal dose; the improvement decreased with further increases in dose. A striking reduction (66.2%-95.7%) in the optimal dose for enhanced retention was observed with these two-drug combinations.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Arecoline / pharmacology
  • Drug Synergism
  • Edrophonium / pharmacology
  • Injections, Subcutaneous
  • Male
  • Memory / drug effects*
  • Mice
  • Oxotremorine / pharmacology
  • Parasympathomimetics / pharmacology*
  • Tacrine / pharmacology

Substances

  • Parasympathomimetics
  • Arecoline
  • Tacrine
  • Oxotremorine
  • Edrophonium